This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: University of Rochester. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2013
Title: Ludmila Bagaeva: Innovator in Neuroinflammatory Disease Research
Introduction
Ludmila Bagaeva is a prominent inventor based in Fairport, NY (US). She has made significant contributions to the field of neuroinflammatory diseases, particularly through her research on lymphoid chemokines. With a total of 2 patents, her work has the potential to impact the diagnosis and treatment of conditions such as multiple sclerosis.
Latest Patents
Bagaeva's latest patents focus on the role of lymphoid chemokines in the diagnosis, monitoring, and treatment of inflammatory diseases. One of her notable studies investigates experimental autoimmune encephalomyelitis (EAE), a Th1-mediated autoimmune disease of the central nervous system. This research demonstrates that CXCL13, a chemokine involved in the development of secondary lymphoid tissues, is expressed in CD11c+ myeloid cells that accumulate in EAE lesions. The findings indicate that blockade or deficiency of CXCL13 can ameliorate clinical EAE during both acute and relapsing stages. Importantly, CXCL13 deficiency does not inhibit the priming or differentiation of autoimmune effector T-cells in the periphery, but it appears to exert its effects during the effector phase of pathogenesis. These insights suggest that reagents that antagonize or inhibit CXCL13 could be beneficial for treating neuroinflammatory diseases such as multiple sclerosis.
Career Highlights
Throughout her career, Bagaeva has worked with esteemed institutions, including the University of Rochester. Her research has garnered attention for its innovative approach to understanding and treating complex autoimmune diseases.
Collaborations
Bagaeva has collaborated with notable professionals in her field, including Benjamin M. Segal, enhancing the impact of her research through shared expertise.
Conclusion
Ludmila Bagaeva's contributions to the field of neuroinflammatory diseases through her patents and research are noteworthy. Her work continues to pave the way for advancements in the diagnosis and treatment of conditions like multiple sclerosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile